E
FendX Technologies Inc. FNDX
CNSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

FendX Technologies Inc. is a Canadian nanotechnology company focused on developing and commercializing surface protection solutions designed to prevent the adhesion of pathogens, dirt, and other contaminants. The company operates at the intersection of advanced materials, nanotechnology, and public health–oriented surface applications, with a strategic emphasis on environments where hygiene and cleanliness are critical. Its core value proposition is the creation of coatings that reduce the need for frequent chemical cleaning by making surfaces easier to clean or resistant to buildup.

The company’s primary business activity centers on the development of nanotechnology-based protective coatings, with its flagship technology branded as RepelWrap™, which is designed to create an invisible, durable layer that reduces surface contamination. FendX targets customers in healthcare, transportation, education, hospitality, and other high-touch public or commercial environments. The company traces its origins to academic research and technology transfer, evolving into a publicly listed entity as it advanced its intellectual property portfolio and moved toward commercialization. Revenue generation to date has been limited, and the company remains in an early-stage, development-focused phase based on publicly available filings.

Business Operations

FendX’s operations are primarily organized around research and development, intellectual property management, and early-stage commercialization of its surface protection technologies. The company does not currently report multiple operating segments; instead, its activities are concentrated on advancing RepelWrap™ through testing, validation, regulatory considerations, and market readiness. As of the most recent public disclosures, the company’s revenue has been minimal or nominal, with funding largely derived from equity financing rather than recurring commercial sales.

Operationally, FendX conducts its work mainly in Canada, leveraging academic partnerships, third-party laboratories, and contract manufacturers rather than owning large-scale production assets. The company maintains control over its proprietary formulations and patents but relies on external partners for testing, scale-up, and potential manufacturing. There are no publicly disclosed major joint ventures generating revenue, and the company’s subsidiary structure is limited, with operations largely housed within the parent entity.

Strategic Position & Investments

FendX’s strategic direction is focused on transitioning from technology development to commercial deployment of its surface coating solutions. Growth initiatives emphasize validating product performance, expanding intellectual property protection, and engaging with potential commercial partners in sectors such as healthcare facilities and public infrastructure. The company has publicly stated intentions to pursue licensing, strategic partnerships, or distribution agreements as pathways to market adoption rather than building extensive internal manufacturing capacity.

The company has made targeted investments in research programs related to nanomaterials and surface chemistry, including continued refinement of RepelWrap™ for durability and scalability. There are no material acquisitions of operating companies disclosed in recent filings, and FendX does not report a diversified portfolio of subsidiaries or investments. Its strategic positioning is that of a single-technology-focused innovator, with future growth dependent on successful commercialization and customer uptake. Where timelines or commercial readiness are discussed in public materials, outcomes remain uncertain, and data is inconclusive based on available public sources.

Geographic Footprint

FendX Technologies Inc. is headquartered in Canada, with its principal executive offices and core operations located domestically. The company’s current operational footprint is primarily national, reflecting its early-stage status and reliance on Canadian research infrastructure and professional service providers.

While FendX markets its technology as applicable to global markets, including North America, Europe, and other international regions, it does not currently report significant overseas operations, offices, or revenue-generating international subsidiaries. Any international presence is limited to preliminary business development, intellectual property coverage, or exploratory discussions, rather than established commercial operations.

Leadership & Governance

FendX is led by a management team with experience in capital markets, technology commercialization, and early-stage company governance. The leadership emphasizes a strategy centered on disciplined capital allocation, intellectual property protection, and strategic partnerships to accelerate commercialization while managing development risk. Governance is overseen by a board of directors consistent with Canadian public company standards.

Key executives include:

  • Carolyn MyersChief Executive Officer
  • Aaron LeeChief Financial Officer
  • Andrew SavageChief Operating Officer
  • George AdamsDirector

The company does not publicly identify a founder in its most recent disclosures, reflecting its evolution from licensed academic research into a standalone public entity. Leadership communications consistently emphasize long-term value creation through technology validation and market adoption rather than near-term revenue growth.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $174.40
B
AAPL NASDAQ $253.79
B
AVGO NASDAQ $309.51
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $124.28
B
Top Financial Stocks
See All »
B
B
JPM NYSE $294.16
B
V NYSE $302.24
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $919.77
B
JNJ NYSE $244.44
B
AMGN NASDAQ $351.85
Top Real Estate Stocks
See All »
B
PLD NYSE $132.18